Stonehage Fleming Financial Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,702
Closed -$420K 230
2024
Q3
$420K Sell
3,702
-13
-0.3% -$1.54K 0.01% 110
2024
Q2
$460K Sell
3,715
-8,239
-69% -$1.06M 0.01% 101
2024
Q1
$1.27M Buy
11,954
+7,822
+189% +$964K 0.08% 35
2023
Q4
$450K Sell
4,132
-2,698
-40% -$280K 0.01% 106
2023
Q3
$710K Sell
6,830
-393
-5% -$42.4K 0.06% 85
2023
Q2
$824K Sell
7,223
-4,731
-40% -$537K 0.03% 74
2023
Q1
$1.27M Buy
11,954
+1,234
+12% +$133K 0.08% 35
2022
Q4
$1.19M Buy
10,720
+3,367
+46% +$344K 0.09% 36
2022
Q3
$637K Hold
7,353
0.05% 63
2022
Q2
$680K Sell
7,353
-376
-5% -$33.3K 0.03% 94
2022
Q1
$636K Buy
7,729
+350
+5% +$27.6K 0.02% 105
2021
Q4
$569K Hold
7,379
0.02% 113
2021
Q3
$554K Sell
7,379
-1,000
-12% -$76.1K 0.02% 110
2021
Q2
$648K Sell
8,379
-557
-6% -$41.4K 0.02% 100
2021
Q1
$656K Buy
8,936
+1,018
+13% +$75.1K 0.02% 100
2020
Q4
$612K Hold
7,918
0.02% 102
2020
Q3
$619K Buy
7,918
+1,703
+27% +$133K 0.02% 90
2020
Q2
$453K Sell
6,215
-11,025
-64% -$830K 0.03% 82
2020
Q1
$1.27M Sell
17,240
-951
-5% -$74.7K 0.06% 48
2019
Q4
$1.58M Hold
18,191
0.07% 47
2019
Q3
$1.46M Hold
18,191
0.07% 49
2019
Q2
$1.46M Hold
18,191
0.07% 48
2019
Q1
$1.44K Buy
18,191
+11,025
+154% +$825K 0.07% 53
2018
Q4
$523K Sell
7,166
-1,048
-13% -$74K 0.03% 101
2018
Q3
$556K Hold
8,214
0.03% 106
2018
Q2
$476K Hold
8,214
0.02% 128
2018
Q1
$427K Hold
8,214
0.03% 125
2017
Q4
$442K Hold
8,214
0.02% 136
2017
Q3
$502K Hold
8,214
0.02% 141
2017
Q2
$502K Hold
8,214
0.03% 135
2017
Q1
$498K Hold
8,214
0.03% 162
2016
Q4
$462K Sell
8,214
-5,529
-40% -$324K 0.03% 166
2016
Q3
$818K Buy
13,743
+5,347
+64% +$313K 0.05% 119
2016
Q2
$462K Buy
8,396
+1,510
+22% +$80.4K 0.03% 145
2016
Q1
$348K Buy
+6,886
New +$337K 0.02% 146
2015
Q1
Sell
-608
Closed -$33K 162
2014
Q4
$33K Buy
+608
New +$33.9K ﹤0.01% 149

Other funds holding MRK

Stonehage Fleming Financial Services's MRK Position: Q4 2024 in Review

Stonehage Fleming Financial Services sold out of Merck (MRK) in Q4 2024, closing a stake of 3,702 shares — an estimated $420K sold.

Stonehage Fleming Financial Services first reported a position in MRK in Q4 2014 and held it in 36 quarters. The position peaked at $1.58M in Q4 2019. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Stonehage Fleming Financial Services reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 3,702 Merck shares in Q4 2024, an estimated $420K.
  • Stonehage Fleming Financial Services first reported a position in Merck in Q4 2014 and held it in 36 quarters.
  • Stonehage Fleming Financial Services's Merck position peaked at $1.58M in Q4 2019.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Stonehage Fleming Financial Services's 13F filing for Q4 2024, filed 22 Jan 2025.